How we score →

Lemonaid Health Review

✓ Updated July 2026 By the TelehealthIndex Editorial Team · How we score Very Good · #1 in Men's Health (ED & TRT) No affiliate relationship
Advertising Disclosure: TelehealthIndex is reader-supported. If you sign up with a provider through links on this page, we may earn a commission at no extra cost to you. Commissions never influence our scores or rankings — several of our top-rated providers pay us nothing. How we score → · Full disclosure →

Lemonaid Health score

Very Good · #1 in Men's Health (ED & TRT) · Data as of July 2026 · No affiliate relationship
Clinical credibilityWeak
Regulatory & safety recordMinor deductions
Transparency & trustStrong
Access & coverageMixed
Customer experienceStrong
Value & pricingGood
Pillar ratings are qualitative summaries of our internal rubric; we do not publish the point weights. Read the full methodology →

TelehealthIndex scores and rankings are editorial opinions resulting from our selection, weighting, and interpretation of the factors described in our methodology.

What it is

Low-cost condition-specific telehealth ($25 consults) with own 50-state pharmacy; LegitScript-certified.

Strengths

  • Available nationwide (50 states)
  • Lower-cost pricing for the category
  • Strong consumer-review signals

Considerations

  • Ownership instability: $10M fire-sale out of 23andMe bankruptcy (2025); new owner unproven
  • Sells compounded ED formulations (disclosed)
Note: this provider offers compounded medications for one or more services. Compounded medications are not FDA-approved.
Founded2013
OwnershipPrivate (Bambu Ventures SPV, 2025)
AvailabilityNationwide (50 states)
InsuranceNo
Money-back guaranteeNot advertised
Pricing$25 one-time consult; meds from $2/pill; depression/anxiety $95/mo incl. meds
Visit Lemonaid Health We may earn a commission — disclosure.

Alternatives to consider

Ro Good · #2 in Men's Health (ED & TRT) — read review → Rex MD Good · #3 in Men's Health (ED & TRT) — read review →

Data as of July 19, 2026. Scores are editorial opinions reflecting documented business practices, transparency, pricing, access, and nonclinical consumer-service factors — not clinical quality or outcomes. Found an error? Report it →